NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,652,642 | +1.3% | 732,895 | +0.3% | 0.30% | +6.9% |
| Q2 2023 | $73,727,630 | +16.3% | 730,628 | +6.1% | 0.28% | +10.0% |
| Q1 2023 | $63,370,152 | -27.2% | 688,806 | -28.3% | 0.25% | -32.2% |
| Q4 2022 | $87,097,369 | -1.9% | 960,068 | -17.8% | 0.37% | -2.4% |
| Q3 2022 | $88,742,000 | -0.4% | 1,167,465 | +10.8% | 0.38% | +3.0% |
| Q2 2022 | $89,078,000 | +31.7% | 1,053,791 | +36.7% | 0.37% | +57.9% |
| Q1 2022 | $67,634,000 | -1.3% | 770,746 | -1.6% | 0.23% | +5.4% |
| Q4 2021 | $68,545,000 | +8.8% | 783,636 | +1.7% | 0.22% | +0.5% |
| Q3 2021 | $63,009,000 | -24.3% | 770,461 | -15.5% | 0.22% | -22.3% |
| Q2 2021 | $83,183,000 | +12.2% | 911,695 | +5.1% | 0.28% | +7.2% |
| Q1 2021 | $74,120,000 | -6.4% | 867,094 | +3.4% | 0.26% | -6.4% |
| Q4 2020 | $79,159,000 | +6.5% | 838,267 | -1.9% | 0.28% | -4.1% |
| Q3 2020 | $74,317,000 | -3.2% | 854,595 | -2.7% | 0.29% | -5.5% |
| Q2 2020 | $76,737,000 | +9.6% | 878,602 | +3.5% | 0.31% | -4.6% |
| Q1 2020 | $70,013,000 | -13.5% | 849,144 | -0.7% | 0.33% | +6.5% |
| Q4 2019 | $80,984,000 | +13.6% | 855,262 | +4.2% | 0.31% | +4.8% |
| Q3 2019 | $71,300,000 | +2.5% | 820,472 | +7.7% | 0.29% | +1.4% |
| Q2 2019 | $69,591,000 | +17.2% | 762,148 | +5.6% | 0.29% | +17.1% |
| Q1 2019 | $59,371,000 | +17.7% | 721,751 | +22.8% | 0.25% | 0.0% |
| Q4 2018 | $50,442,000 | +18.0% | 587,842 | +18.5% | 0.25% | +39.0% |
| Q3 2018 | $42,744,000 | +20.1% | 496,103 | +5.3% | 0.18% | +14.9% |
| Q2 2018 | $35,577,000 | -4.9% | 470,982 | +1.8% | 0.15% | -7.2% |
| Q1 2018 | $37,423,000 | +6.3% | 462,868 | +10.4% | 0.17% | +9.2% |
| Q4 2017 | $35,196,000 | +10.6% | 419,198 | +13.1% | 0.15% | +5.6% |
| Q3 2017 | $31,819,000 | +13.3% | 370,621 | +10.1% | 0.14% | +7.5% |
| Q2 2017 | $28,088,000 | +19.0% | 336,503 | +5.9% | 0.13% | +15.5% |
| Q1 2017 | $23,595,000 | +173.3% | 317,697 | +168.1% | 0.12% | +152.2% |
| Q4 2016 | $8,632,000 | -31.6% | 118,499 | -25.8% | 0.05% | -33.3% |
| Q3 2016 | $12,617,000 | +9.3% | 159,785 | +14.2% | 0.07% | +7.8% |
| Q2 2016 | $11,546,000 | -5.3% | 139,936 | -16.9% | 0.06% | -8.6% |
| Q1 2016 | $12,193,000 | -25.6% | 168,321 | -11.7% | 0.07% | -27.1% |
| Q4 2015 | $16,397,000 | -25.8% | 190,578 | -20.7% | 0.10% | -30.4% |
| Q3 2015 | $22,103,000 | -0.7% | 240,459 | +6.3% | 0.14% | +3.8% |
| Q2 2015 | $22,252,000 | +7.2% | 226,285 | +7.5% | 0.13% | +6.4% |
| Q1 2015 | $20,756,000 | +55.0% | 210,485 | +45.6% | 0.12% | +48.8% |
| Q4 2014 | $13,394,000 | +72.6% | 144,550 | +75.3% | 0.08% | +68.0% |
| Q3 2014 | $7,760,000 | -42.5% | 82,444 | -44.7% | 0.05% | -46.8% |
| Q2 2014 | $13,504,000 | +5.7% | 149,164 | -0.7% | 0.09% | +2.2% |
| Q1 2014 | $12,770,000 | +0.2% | 150,205 | -5.3% | 0.09% | -1.1% |
| Q4 2013 | $12,747,000 | +7.0% | 158,583 | +2.1% | 0.09% | -4.1% |
| Q3 2013 | $11,914,000 | – | 155,313 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |